-
2025-521158-40-00
4
2025-09-12
oesophageal cancer
-
2025-520483-17-01
6
2025-09-02
Systemic sclerosis
-
2024-519667-18-00
6
2025-08-21
Pancreatic conditions requiring pancreaticoduodenectomy, such as pancr
-
2023-510333-28-00
5
2025-08-20
Uveal Melanoma
-
2024-517972-39-00
5
2025-08-19
Autoimmune haemolytic anaemia
-
2025-522281-68-00
3
2025-08-08
Generalized Anxiety Disorder (GAD)
-
2024-516095-15-00
1
2025-08-05
Kidney Disease
-
2024-515561-34-01
6
2025-08-04
Acute ischemic stroke with recent ingestion of direct oral anticoagula
-
2024-512583-57-00
5
2025-07-30
HER2-positive locally advanced or metastatic gastric or gastroesophage
-
2024-514740-82-00
6
2025-07-16
Inflammatory Bowel Disease
-
2024-512466-34-00
5
2025-07-10
High grade glioma (HGG)
-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2024-513255-32-00
10
2025-07-03
Advanced gastric cancer
-
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
-
2024-514947-27-00
9
2025-06-18
Advance solid tumors
-
2025-521357-17-00
1
2025-06-13
Parkinson's disease
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2023-503313-30-01
5
2025-04-14
Head and Neck squamous cell carcinoma
-
2024-517343-31-00
6
2025-04-11
Ischemic stroke and transient ischemic attack
-
2024-516068-27-01
5
2025-04-10
cardiopulmonary resuscitation
-
2023-510137-29-01
4
2025-04-09
Cerebral Amyloid Angiopathy (CAA) is a neurological condition in which
-
2023-508507-20-00
5
2025-04-03
Locally advanced or metastatic conventional chondrosarcoma with an IDH